Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
Status: | Active, not recruiting |
---|---|
Conditions: | Food Studies |
Therapuetic Areas: | Pharmacology / Toxicology |
Healthy: | No |
Age Range: | 18 - 75 |
Updated: | 3/23/2019 |
Start Date: | June 26, 2018 |
End Date: | July 2019 |
A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study
conducted in the United States (US) to assess the efficacy of RP-G28 compared to placebo on
symptom reduction related to lactose intolerance.
conducted in the United States (US) to assess the efficacy of RP-G28 compared to placebo on
symptom reduction related to lactose intolerance.
Inclusion Criteria:
- Patient is 18-75 years of age, inclusive, at screening;
- Intolerance to milk and other dairy products;
- Patient agrees to refrain from all other treatments and products used for lactose
intolerance, to follow diet modifications required during periods of the study that
include abstinence from all dairy in some periods and consuming dairy in other
periods;
- Patient meets the defined minimum lactose intolerance symptom composite score; and
- Patient has positive Hydrogen Breath Test (HBT) results for lactase deficiency.
Exclusion Criteria:
- Patient has a disorder associated with abnormal gastrointestinal motility such as
gastroparesis (from any cause), amyloidosis, neuromuscular diseases (including
Parkinson's disease), collagen vascular diseases, uremia, or malnutrition;
- Patient has undergone bowel preparation for endoscopic or radiologic investigation
within 4 weeks of Screening (example, colonoscopy preparation);
- Patient has a history of surgery that alters the normal function of the
gastrointestinal tract including, but not limited to: fundoplication, gastrointestinal
bypass surgery, bariatric surgery, gastric banding, colostomy, vagotomy, pyloroplasty,
colectomy or other surgery for Crohn's disease or ulcerative colitis; and
- Patient has received antibiotic treatment, or had a high colonic enema, colonic
irrigation, colonic hydrotherapy, or colonic cleaning within 30 days prior to or
during Screening.
We found this trial at
34
sites
Omaha, Nebraska
Principal Investigator: Ronald Anderson
Phone: 402-934-0044
Click here to add this to my saved trials
Albuquerque, New Mexico
Principal Investigator: Ellen Kim
Phone: 505-224-7407
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Birmingham, Alabama
Principal Investigator: David DeAtkine, MD
Phone: 205-327-1077
Click here to add this to my saved trials
Click here to add this to my saved trials
Charleston, South Carolina 29412
Phone: 843-818-1181
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Colorado Springs, Colorado 80910
Principal Investigator: Kari T Uusinarkaus
Phone: 719-226-8020
Click here to add this to my saved trials
Dayton, Ohio 45409
Principal Investigator: Steven Folkerth
Phone: 937-297-8999
Click here to add this to my saved trials
Fairfax, Virginia 22031
Principal Investigator: Kenneth Mirkin
Phone: 703-689-9860
Click here to add this to my saved trials
Gainesville, Florida 32610
Principal Investigator: Bruce K Branin, DO
Phone: 352-538-5407
Click here to add this to my saved trials
Great Neck, New York 11021
Principal Investigator: Michael J Goldstein, MD
Phone: 516-482-5976
Click here to add this to my saved trials
Hartsdale, New York
Principal Investigator: Michael Gerdis, MD
Phone: 914-341-2346
Click here to add this to my saved trials
Honolulu, Hawaii
Principal Investigator: Pantea Shoja
Phone: 614-430-8022
Click here to add this to my saved trials
Houston, Texas
Principal Investigator: Francisco D Velazquez, MD
Phone: 713-333-9323
Click here to add this to my saved trials
Huntington Park, California 90255
Phone: 323-588-1968
Click here to add this to my saved trials
Knoxville, Tennessee 37920
Principal Investigator: Evelyne M Davidson, MD
Phone: 865-200-8364
Click here to add this to my saved trials
Click here to add this to my saved trials
Lincoln, California 95648
Principal Investigator: Jeffrey D Wayne, MD
Phone: 916-434-8230
Click here to add this to my saved trials
Click here to add this to my saved trials
Marrero, Louisiana 70072
Principal Investigator: Gary Reiss
Phone: 504-934-8424
Click here to add this to my saved trials
Click here to add this to my saved trials
Orlando, Florida 32804
Principal Investigator: Judith L White, MD
Phone: 407-426-9299
Click here to add this to my saved trials
Oxon Hill, Maryland 20745
Principal Investigator: Stephen Ong
Phone: 301-839-2916
Click here to add this to my saved trials
Panorama City, California
Principal Investigator: Juan Frias
Phone: 818-532-6880
Click here to add this to my saved trials
Pompano Beach, Florida 33060
Principal Investigator: Daniel Lindenberg
Phone: 646-265-9823
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
San Diego, California
Principal Investigator: Taddese T Desta, MD
Phone: 858-277-5678
Click here to add this to my saved trials
Walnut Creek, California 94598
Principal Investigator: Helen Stacey
Phone: 925-930-7392
Click here to add this to my saved trials
Click here to add this to my saved trials
Wyoming, Michigan 45519
Principal Investigator: Allan Coates
Phone: 616-328-5344
Click here to add this to my saved trials